Prevalence of Cardiovascular Risk Factors in Osteoarthritis Patients Derived from Primary Care Records: A Systematic

Xiaoyang Huang1, Ross Wilkie1, Mamas A Mamas2

  • 1Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK.

Journal of Diabetes and Clinical Research
|July 5, 2022
PubMed

Insights

People with osteoarthritis have higher cardiovascular disease (CVD) risk factors, including hypertension and obesity. Primary care electronic health records (EHRs) show these elevated risks, aiding CVD management in osteoarthritis patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Health Informatics

Background:

  • Osteoarthritis (OA) patients face elevated risks for cardiovascular disease (CVD).
  • Early detection of CVD risk factors in OA populations is crucial for improving patient outcomes.
  • Primary care electronic health records (EHRs) offer a valuable resource for monitoring CVD risk factors in individuals with OA.

Purpose of the Study:

  • To systematically review the prevalence of CVD risk factors in individuals with osteoarthritis, utilizing data from primary care EHRs.
  • To summarize existing evidence on the frequency of key CVD risk factors within the OA patient demographic.

Main Methods:

  • A systematic literature search was conducted across eight databases, including MEDLINE, up to January 2019.
  • Included were observational studies that used primary care EHR data to assess the prevalence of six defined CVD risk factors in people with osteoarthritis.
  • A narrative review approach was employed to synthesize the findings from the identified studies.

Main Results:

  • Six studies met the inclusion criteria, exhibiting significant heterogeneity that precluded pooled analysis.
  • Prevalence estimates varied: smoking (12.5%), hypertension (19.7%-55.5%), obesity (34.4%-51.6%), dyslipidemia (6.0%, 13.3%), and diabetes (5.2%-18.6%).
  • One study indicated higher odds of hypertension, obesity, dyslipidemia, and diabetes in OA patients compared to controls.

Conclusions:

  • Primary care EHR data suggest a higher prevalence of CVD risk factors in individuals with osteoarthritis compared to those without OA.
  • These findings provide a baseline understanding of CVD risk factor frequency in OA patients within primary care settings.
  • Further research using EHRs is warranted to explore their utility in evaluating strategies for managing CVD risk in the OA population.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
49
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
36
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
463
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
30
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
36